Acutus Medical Statistics
Total Valuation
Acutus Medical has a market cap or net worth of $4.98 million. The enterprise value is $14.03 million.
| Market Cap | 4.98M |
| Enterprise Value | 14.03M |
Important Dates
The next estimated earnings date is Thursday, May 9, 2024, after market close.
| Earnings Date | May 9, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Acutus Medical has 29.72 million shares outstanding. The number of shares has increased by 3.46% in one year.
| Shares Outstanding | 29.72M |
| Shares Change (YoY) | +3.46% |
| Shares Change (QoQ) | +0.14% |
| Owned by Insiders (%) | 3.61% |
| Owned by Institutions (%) | 23.51% |
| Float | 23.42M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.70 |
| Forward PS | 0.15 |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.96 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.44
| Current Ratio | 2.44 |
| Quick Ratio | 2.15 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -13.43 |
Financial Efficiency
Return on equity (ROE) is -241.90% and return on invested capital (ROIC) is -30.86%.
| Return on Equity (ROE) | -241.90% |
| Return on Assets (ROA) | -92.00% |
| Return on Capital (ROIC) | -30.86% |
| Revenue Per Employee | $31,148 |
| Profits Per Employee | -$355,057 |
| Employee Count | 230 |
| Asset Turnover | 0.08 |
| Inventory Turnover | 3.39 |
Taxes
In the past 12 months, Acutus Medical has paid $63,000 in taxes.
| Income Tax | 63,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -79.56% in the last 52 weeks. The beta is 0.20, so Acutus Medical's price volatility has been lower than the market average.
| Beta (1Y) | 0.20 |
| 52-Week Price Change | -79.56% |
| 50-Day Moving Average | 0.19 |
| 200-Day Moving Average | 0.39 |
| Relative Strength Index (RSI) | 44.88 |
| Average Volume (30 Days) | 2,353,000 |
Short Selling Information
The latest short interest is 845,166, so 2.84% of the outstanding shares have been sold short.
| Short Interest | 845,166 |
| Short Previous Month | 984,699 |
| Short % of Shares Out | 2.84% |
| Short % of Float | 3.61% |
| Short Ratio (days to cover) | 1.09 |
Income Statement
In the last 12 months, Acutus Medical had revenue of $7.16 million and -$81.66 million in losses. Loss per share was -$2.81.
| Revenue | 7.16M |
| Gross Profit | -3.14M |
| Operating Income | -11.61M |
| Pretax Income | -81.60M |
| Net Income | -81.66M |
| EBITDA | -75.07M |
| EBIT | -75.95M |
| Loss Per Share | -$2.81 |
Balance Sheet
The company has $29.43 million in cash and $38.48 million in debt, giving a net cash position of -$9.05 million or -$0.30 per share.
| Cash & Cash Equivalents | 29.43M |
| Total Debt | 38.48M |
| Net Cash | -9.05M |
| Net Cash Per Share | -$0.30 |
| Equity / Book Value | -879,000 |
| Book Value Per Share | -0.03 |
| Working Capital | 27.31M |
Cash Flow
In the last 12 months, operating cash flow was -$63.12 million and capital expenditures -$219,000, giving a free cash flow of -$63.34 million.
| Operating Cash Flow | -63.12M |
| Capital Expenditures | -219,000 |
| Free Cash Flow | -63.34M |
| FCF Per Share | -$2.16 |
Margins
Gross margin is -43.79%, with operating and profit margins of -161.99% and -1,139.91%.
| Gross Margin | -43.79% |
| Operating Margin | -161.99% |
| Pretax Margin | -1,139.03% |
| Profit Margin | -1,139.91% |
| EBITDA Margin | -1,047.89% |
| EBIT Margin | -1,060.09% |
| FCF Margin | -884.10% |
Dividends & Yields
Acutus Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.46% |
| Shareholder Yield | -3.46% |
| Earnings Yield | -1,639.69% |
| FCF Yield | -1,271.72% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Acutus Medical has an Altman Z-Score of -19.42 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -19.42 |
| Piotroski F-Score | 4 |